ID KC1AL_HUMAN Reviewed; 337 AA. AC Q8N752; Q5T2N2; DT 10-MAY-2004, integrated into UniProtKB/Swiss-Prot. DT 22-JUL-2008, sequence version 2. DT 08-NOV-2023, entry version 165. DE RecName: Full=Casein kinase I isoform alpha-like; DE Short=CKI-alpha-like; DE EC=2.7.11.1; DE AltName: Full=CK1; GN Name=CSNK1A1L; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057823; DOI=10.1038/nature02379; RA Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., RA Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., RA Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., RA Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L., RA Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P., RA Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P., RA Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C., RA Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P., RA Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L., RA Frankish A.G., Frankland J., French L., Garner P., Garnett J., RA Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M., RA Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D., RA Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D., RA Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., RA Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S., RA Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., RA Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R., RA Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W., RA Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., RA Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L., RA Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R., RA Rogers J., Ross M.T.; RT "The DNA sequence and analysis of human chromosome 13."; RL Nature 428:522-528(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-42. RC TISSUE=Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP VARIANT [LARGE SCALE ANALYSIS] GLN-21. RX PubMed=16959974; DOI=10.1126/science.1133427; RA Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., RA Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., RA Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V., RA Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., RA Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., RA Velculescu V.E.; RT "The consensus coding sequences of human breast and colorectal cancers."; RL Science 314:268-274(2006). RN [5] RP VARIANTS [LARGE SCALE ANALYSIS] GLY-5; TRP-21; SER-170; LYS-177; LEU-220; RP ASN-230 AND THR-257. RX PubMed=17344846; DOI=10.1038/nature05610; RA Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., RA Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., RA Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., RA Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., RA Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., RA Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., RA Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., RA Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., RA Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., RA Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., RA Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., RA Futreal P.A., Stratton M.R.; RT "Patterns of somatic mutation in human cancer genomes."; RL Nature 446:153-158(2007). CC -!- FUNCTION: Casein kinases are operationally defined by their CC preferential utilization of acidic proteins such as caseins as CC substrates. It can phosphorylate a large number of proteins. CC Participates in Wnt signaling (By similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl- CC [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA- CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L- CC threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, CC Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; CC EC=2.7.11.1; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. CC -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr CC protein kinase family. Casein kinase I subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL391383; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471075; EAX08587.1; -; Genomic_DNA. DR EMBL; BC028723; AAH28723.1; -; mRNA. DR CCDS; CCDS9363.1; -. DR RefSeq; NP_660204.2; NM_145203.5. DR AlphaFoldDB; Q8N752; -. DR SMR; Q8N752; -. DR BioGRID; 125755; 66. DR IntAct; Q8N752; 18. DR MINT; Q8N752; -. DR STRING; 9606.ENSP00000369126; -. DR BindingDB; Q8N752; -. DR ChEMBL; CHEMBL5520; -. DR DrugCentral; Q8N752; -. DR iPTMnet; Q8N752; -. DR PhosphoSitePlus; Q8N752; -. DR SwissPalm; Q8N752; -. DR BioMuta; CSNK1A1L; -. DR DMDM; 212286065; -. DR jPOST; Q8N752; -. DR MassIVE; Q8N752; -. DR MaxQB; Q8N752; -. DR PaxDb; 9606-ENSP00000369126; -. DR PeptideAtlas; Q8N752; -. DR ProteomicsDB; 72263; -. DR Pumba; Q8N752; -. DR Antibodypedia; 42131; 195 antibodies from 26 providers. DR DNASU; 122011; -. DR Ensembl; ENST00000379800.4; ENSP00000369126.3; ENSG00000180138.7. DR GeneID; 122011; -. DR KEGG; hsa:122011; -. DR MANE-Select; ENST00000379800.4; ENSP00000369126.3; NM_145203.6; NP_660204.2. DR UCSC; uc001uwm.2; human. DR AGR; HGNC:20289; -. DR CTD; 122011; -. DR DisGeNET; 122011; -. DR GeneCards; CSNK1A1L; -. DR HGNC; HGNC:20289; CSNK1A1L. DR HPA; ENSG00000180138; Tissue enriched (testis). DR neXtProt; NX_Q8N752; -. DR OpenTargets; ENSG00000180138; -. DR PharmGKB; PA134917108; -. DR VEuPathDB; HostDB:ENSG00000180138; -. DR eggNOG; KOG1163; Eukaryota. DR GeneTree; ENSGT00940000164967; -. DR HOGENOM; CLU_019279_2_7_1; -. DR InParanoid; Q8N752; -. DR OMA; CPPRIRT; -. DR OrthoDB; 1534388at2759; -. DR PhylomeDB; Q8N752; -. DR TreeFam; TF354246; -. DR PathwayCommons; Q8N752; -. DR SignaLink; Q8N752; -. DR SIGNOR; Q8N752; -. DR BioGRID-ORCS; 122011; 7 hits in 1147 CRISPR screens. DR GenomeRNAi; 122011; -. DR Pharos; Q8N752; Tdark. DR PRO; PR:Q8N752; -. DR Proteomes; UP000005640; Chromosome 13. DR RNAct; Q8N752; Protein. DR Bgee; ENSG00000180138; Expressed in blood and 11 other tissues. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA. DR GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central. DR GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IBA:GO_Central. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR GO; GO:0007165; P:signal transduction; IBA:GO_Central. DR GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW. DR CDD; cd14128; STKc_CK1_alpha; 1. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR017441; Protein_kinase_ATP_BS. DR InterPro; IPR008271; Ser/Thr_kinase_AS. DR PANTHER; PTHR11909:SF139; CASEIN KINASE I ISOFORM ALPHA-LIKE; 1. DR PANTHER; PTHR11909; CASEIN KINASE-RELATED; 1. DR Pfam; PF00069; Pkinase; 1. DR SMART; SM00220; S_TKc; 1. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS00108; PROTEIN_KINASE_ST; 1. PE 2: Evidence at transcript level; KW Acetylation; ATP-binding; Cytoplasm; Kinase; Nucleotide-binding; KW Reference proteome; Serine/threonine-protein kinase; Transferase; KW Wnt signaling pathway. FT CHAIN 1..337 FT /note="Casein kinase I isoform alpha-like" FT /id="PRO_0000192830" FT DOMAIN 17..285 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT REGION 309..337 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 309..328 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 136 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159, FT ECO:0000255|PROSITE-ProRule:PRU10027" FT BINDING 23..31 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 46 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT MOD_RES 8 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P48729" FT VARIANT 5 FT /note="S -> G (in dbSNP:rs56224973)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042074" FT VARIANT 21 FT /note="R -> Q (in a colorectal cancer sample; somatic FT mutation; dbSNP:rs373362769)" FT /evidence="ECO:0000269|PubMed:16959974" FT /id="VAR_036450" FT VARIANT 21 FT /note="R -> W (in dbSNP:rs56158728)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042075" FT VARIANT 42 FT /note="D -> E (in dbSNP:rs9576175)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_042076" FT VARIANT 170 FT /note="R -> S (in dbSNP:rs17773251)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_034047" FT VARIANT 177 FT /note="E -> K (in dbSNP:rs17054882)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042077" FT VARIANT 220 FT /note="P -> L (in dbSNP:rs56252856)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042078" FT VARIANT 230 FT /note="K -> N (in dbSNP:rs56252523)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042079" FT VARIANT 257 FT /note="A -> T (in dbSNP:rs55895045)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042080" FT CONFLICT 225 FT /note="R -> K (in Ref. 3; AAH28723)" FT /evidence="ECO:0000305" SQ SEQUENCE 337 AA; 39086 MW; 6110F854D739B142 CRC64; MTNNSGSKAE LVVGGKYKLV RKIGSGSFGD VYLGITTTNG EDVAVKLESQ KVKHPQLLYE SKLYTILQGG VGIPHMHWYG QEKDNNVLVM DLLGPSLEDL FNFCSRRFTM KTVLMLADQM ISRIEYVHTK NFLHRDIKPD NFLMGTGRHC NKLFLIDFGL AKKYRDNRTR QHIPYREDKH LIGTVRYASI NAHLGIEQSR RDDMESLGYV FMYFNRTSLP WQGLRAMTKK QKYEKISEKK MSTPVEVLCK GFPAEFAMYL NYCRGLRFEE VPDYMYLRQL FRILFRTLNH QYDYTFDWTM LKQKAAQQAA SSSGQGQQAQ TQTGKQTEKN KNNVKDN //